Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R89674 (Lastacaft) in seasonal allergic conjunctivitis
NCT00364091Phase 3Completed
- Start
- Aug 2006
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alcaftadine in seasonal allergic conjunctivitis (SAC). Started Aug 2006; status: completed.
02
Drugs
alcaftadine
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT00364091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364091.